What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?

Background: Reactivation of Hepatitis B (HBVr) related to immunosuppressive drug therapy (ISDT) in patients with resolved and past infection is a challenging entity. The number of prospective long-term studies is limited. Methods: Two groups of patients with resolved and past HBV infection were an...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Salih Tokmak, Yüksel Gümürdülü, Didem A. Taş, İbrahim O. Kara, Ahmet B. Güzel
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Turkish Society of Gastroenterology 2021-03-01
Saila:	The Turkish Journal of Gastroenterology
Gaiak:	Hepatitis B antigens rituximab prophylaxis immunosuppressants antineoplastic agents
Sarrera elektronikoa:	https://turkjgastroenterol.org/index.php/tjg/article/view/3716
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!